Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome.

Aharonovich E, Garawi F, Bisaga A, Brooks D, Raby WN, Rubin E, Nunes EV, Levin FR.

Am J Drug Alcohol Abuse. 2006;32(4):629-35.

PMID:
17127551
2.

ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.

Kollins SH.

J Atten Disord. 2008 Sep;12(2):115-25. doi: 10.1177/1087054707311654. Epub 2008 Jan 11. Review.

PMID:
18192623
3.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
4.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
6.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
7.

[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].

Wiesegger G, Kienbacher C, Pellegrini E, Scheidinger H, Vesely C, Bangerl W, Friedrich M.

Neuropsychiatr. 2007;21(3):187-206. Review. German.

PMID:
17915180
8.

Attention deficit hyperactivity disorder and substance use disorders.

Szobot CM, Bukstein O.

Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):309-23, viii. doi: 10.1016/j.chc.2007.11.003. Review.

PMID:
18295148
9.
10.

Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults.

Vaughan BS, Wetzel MW, Kratochvil CJ.

Int Rev Psychiatry. 2008 Apr;20(2):143-9. doi: 10.1080/09540260801887751. Review.

PMID:
18386204
11.

Optimizing therapy of seizures in children and adolescents with ADHD.

Aldenkamp AP, Arzimanoglou A, Reijs R, Van Mil S.

Neurology. 2006 Dec 26;67(12 Suppl 4):S49-51. Review.

PMID:
17190923
12.

[Substance use disorders and ADHD: an overview of recent Dutch research].

van Emmerik-van Oortmerssen K, Crunelle CL, Carpentier PJ.

Tijdschr Psychiatr. 2013;55(11):861-6. Review. Dutch.

13.

Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.

Upadhyaya HP.

J Clin Psychiatry. 2007;68 Suppl 11:23-30. Review.

PMID:
18307378
14.

Attention deficit/hyperactivity disorder in adults.

Moss SB, Nair R, Vallarino A, Wang S.

Prim Care. 2007 Sep;34(3):445-73, v. Review.

PMID:
17868755
15.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
16.

[Cocaine and other psychostimulant consumption: their relationship with the childhood hyperactivity syndrome].

Ros Soler A, Valoria Martínez A, Nieto Munuera J.

Actas Esp Psiquiatr. 2004 Nov-Dec;32(6):346-52. Review. Spanish.

PMID:
15529223
17.

Comorbidity: cannabis and complexity.

Raphael B, Wooding S, Stevens G, Connor J.

J Psychiatr Pract. 2005 May;11(3):161-76. Review.

PMID:
15920390
18.

Clinical evaluation of substance abuse.

Kaul P, Coupey SM.

Pediatr Rev. 2002 Mar;23(3):85-94. Review. No abstract available.

PMID:
11875181
19.

The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update.

Mariani JJ, Khantzian EJ, Levin FR.

Am J Addict. 2014 Mar-Apr;23(2):189-93. doi: 10.1111/j.1521-0391.2013.12086.x. Epub 2013 Sep 13. Review.

20.

Development and consequences of cannabis dependence.

Budney AJ, Moore BA.

J Clin Pharmacol. 2002 Nov;42(11 Suppl):28S-33S. Review.

PMID:
12412833
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk